Thumbnail Image

Antimicrobial resistance: definitions for adoption








Related items

Showing items related by metadata.

  • Thumbnail Image
    Meeting
    Antimicrobial use in aquaculture and antimicrobial resistance. Report of a Joint FAO/OIE/WHO Expert Consultation on Antimicrobial Use in Aquaculture and Antimicrobial Resistance
    Seoul, Republic of Korea, 13-16 June 2006
    2006
    Also available in:
    No results found.

    The public health hazards related to antimicrobial use in aquaculture include the development and spread of antimicrobial resistant bacteria and resistance genes, and the occurrence of antimicrobial residues in products of aquaculture. The greatest potential risk to public health associated with antimicrobial use in aquaculture is thought to be the development of a reservoir of transferable resistance genes in bacteria in aquatic environments from which such genes can be disseminated by horizont al gene transfer to other bacteria and ultimately reach human pathogens. However, a quantitative risk assessment on antimicrobial resistance in aquaculture is difficult to perform owing to lack of data and the many different and complex pathways of gene flow.
  • Thumbnail Image
    Meeting
    Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific assessment
    Geneva, December 1 – 5, 2003
    2003
    Also available in:
    No results found.

    Antimicrobial agents are essential drugs for human and animal health and welfare. Antimicrobial resistance is a global public health concern that is impacted by both human and non-human antimicrobial usage. Antimicrobial agents are used in food animals, including from aquaculture, companion animals and horticulture to treat or prevent disease. Antimicrobial agents are sometimes used in food animals to promote growth. The types of antimicrobials used are frequently the same as, or closely rela ted to, antimicrobials used in humans.

    The expert workshop concluded that there is clear evidence of adverse human health consequences due to resistant organisms resulting from non-human usage of antimicrobials. These consequences include infections that would not have otherwise occurred, increased frequency of treatment failures (in some cases death) and increased severity of infections, as documented for instance by fluoroquinolone resistant human Salmonella infections. Evidence shows th at the amount and pattern of non-human usage of antimicrobials impact on the occurrence of resistant bacteria in animals and on food commodities and thereby human exposure to these resistant bacteria. The foodborne route is the major transmission pathway for resistant bacteria and resistance genes from food animals to humans, but other routes of transmission exist. There is much less data available on the public health impact of antimicrobial usage in aquaculture, horticulture and companion an imals.

  • Thumbnail Image
    Book (stand-alone)
    Antimicrobial Resistance Multi-Partner Trust Fund: Forging Tripartite collaboration for urgent global and country action against antimicrobial resistance (AMR)
    Annual Progress Report 2020
    2021
    Also available in:
    No results found.

    In 2019, the Tripartite Joint Secretariat (FAO, OIE, and WHO) launched the AMR Multi-Partner Trust Fund (MPTF) to scale up action in low- and lower-middle-income countries to address antimicrobial resistance (AMR) as well as set up joint, global-level activities. In 2020, the Tripartite put in place the necessary frameworks, tools, and standards to select countries and develop global programmes that will be supported by the MPTF. The following report will provide an overview of the country and global projects, their current implementation status, the fund’s financial resources as well as the next steps.

Users also downloaded

Showing related downloaded files

No results found.